Aspire commences initial production of pre-workout performance supplement

Aspire Biopharma (ASBP) has begun initial production of its single dose pre workout supplement utilizing Aspire’s patent-pending and proprietary sublingual delivery technology. The clinically dosed pre-workout formula is expected to be conveniently packaged in a single serving sachet for easy on-the-go use. The Company expects to begin consumer and safety testing of this supplement product during the second quarter of 2025. Aspire’s initial pre-workout supplement features 100mg of caffeine as well as beta alanine and is designed to support sustained energy and mental focus, helping athletes and fitness enthusiasts maximize their performance potential. Aspire’s sachets are easy to use, do not need to be mixed with water, and contain a precise amount of caffeine.